Suppr超能文献

纳曲酮治疗贪食症:将饮食失调与药物滥用相联系的临床及理论研究结果

Naltrexone treatment of bulimia: clinical and theoretical findings linking eating disorders and substance abuse.

作者信息

Jonas J M, Gold M S

机构信息

Eating Disorders Program and Research Facilities, Fair Oaks Hospital, Summit, NJ 07901.

出版信息

Adv Alcohol Subst Abuse. 1987;7(1):29-37.

PMID:2831700
Abstract

Eating disorders and substance abuse may occur together frequently. Studies have demonstrated that 25%-50% of individuals with anorexia nervosa and bulimia will have a history of substance abuse, and that certain groups of drug abusers may have elevated rates of eating disorders. One mechanism which may explain this relationship is the role of endogenous opiate peptides in triggering the compulsion to binge-eat. The authors report the successful use of the long-acting opiate antagonist naltrexone in treating a group of bulimic individuals, and discuss the implications of these findings.

摘要

饮食失调和药物滥用可能经常同时出现。研究表明,25%至50%的神经性厌食症和贪食症患者有药物滥用史,而且某些吸毒人群的饮食失调发生率可能更高。一种可能解释这种关系的机制是内源性阿片肽在引发暴饮暴食冲动中所起的作用。作者报告了长效阿片拮抗剂纳曲酮在治疗一组贪食症患者中的成功应用,并讨论了这些发现的意义。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验